- Home
- / Algorae Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Algorae Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-09-29
Market Capitalization
$22.9 M
2023-09-29
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 730.0K | 647.0K | 450.0K | 244.0K | ||||
| Gross profit | 730.0K | 647.0K | 1.6M | 366.0K | ||||
| Gross profit margin, % | 100.0% | 100.0% | 355.1% | 150.0% | ||||
| Operating expense total | 4.3M | 4.1M | 3.1M | 2.3M | 2.4M | 2.1M | 2.2M | 1.7M |
| Depreciation and amortization | 62.0K | 52.0K | 17.0K | 5.0K | 1.0K | 1.0K | ||
| EBITDA | (538.0K) | (3.4M) | (1.5M) | (1.9M) | (2.4M) | (2.1M) | (2.2M) | (1.7M) |
| EBITDA margin, % | -73.7% | -528.7% | -340.9% | -782.0% | ||||
| EBIT | (600.0K) | (3.6M) | (1.7M) | (1.9M) | (2.4M) | (2.1M) | (2.2M) | (1.7M) |
| EBIT margin, % | -82.2% | -551.3% | -377.6% | -784.0% | ||||
| Interest income | 149.0K | 123.0K | 56.0K | 8.0K | 3.0K | 42.0K | 125.0K | 141.0K |
| Interest expense | 3.0K | |||||||
| Pre tax profit | (576.0K) | (3.5M) | (1.3M) | (1.9M) | (2.4M) | (2.1M) | (2.1M) | (1.5M) |
| Income tax expense | (202.0K) | (296.0K) | (377.0K) | (445.0K) | (415.0K) | (737.0K) | ||
| Net Income | (374.0K) | (3.2M) | (968.0K) | (1.5M) | (2.0M) | (2.1M) | (2.1M) | (803.0K) |